Skip Links
Patients & carers
We are currently in the mid-stages of clinical studies with our NPL-2003 program.
Additional studies will be required before this compound can be submitted for approval, thus no date has been set for product introduction.
Back to top
Neuropharm Group plc Fetcham Park House Lower Road Leatherhead Surrey KT22 9HD United Kingdom
T: +44 (0)1372 371 171
Email: UK office